CAAS Capital Management’s Biodesix BDSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BDSX
BC
ACM
KCM
PI
OIM
FAM
RI
CAAS Capital Management's BDSX Position: Q1 2021 in Review
CAAS Capital Management sold out of Biodesix (BDSX) in Q1 2021, closing a stake of 1,000 shares — an estimated $403K sold.
CAAS Capital Management first reported a position in BDSX in Q4 2020 and held it in 1 quarter. The position peaked at $403K in Q4 2020. 46 funds tracked by Wall St. Rank hold BDSX as of Q1 2021.
- CAAS Capital Management reported no remaining Biodesix position as of Q1 2021 after selling out during the quarter.
- CAAS Capital Management sold 1,000 Biodesix shares in Q1 2021, an estimated $403K.
- CAAS Capital Management first reported a position in Biodesix in Q4 2020 and held it in 1 quarter.
- CAAS Capital Management's Biodesix position peaked at $403K in Q4 2020.
- 46 funds tracked by Wall St. Rank held Biodesix as of Q1 2021.
Based on CAAS Capital Management's 13F filing for Q1 2021, filed 17 May 2021.